Investegate |BioNTech SE Announcements | BioNTech SE: BioNTech Plans to Initiate the Construction of an mRNA Vaccine Manufacturing Facility in Africa in mid-2022

Investegate announcements from BioNTech SE, BioNTech Plans to Initiate the Construction of an mRNA Vaccine Manufacturing Facility in Africa in mid-2022

Related Keywords

Germany ,United States ,United Kingdom ,Kigali ,W09 ,Rwanda ,South Africa ,Canada ,Senegal ,Rwandan ,Republic Of Rwanda ,Danielm Ngamije ,Monique Nsanzabaganwa ,Sierk Poetting ,Sabin Nsanzimana ,Fosun Pharma ,Sylke Maas ,Matshidiso Moeti ,Alpha Sall ,Ugur Sahin ,Deputy Chairperson Of The African Union Commission ,Genentech ,World Health Organization Regional ,Bayer Animal Health ,Rwanda Biomedical Centre ,Pfizer ,Rwanda Development Board ,Second Ministerial Meeting Of The African Union ,European Union ,Enup Foundation ,European Investment Bank ,European Commission ,Foreign Affairs ,Roche Group ,African Union ,Manufacturing Facility ,Rwandan Government ,Tall Sall ,Institut Pasteur De Dakar ,Second Ministerial Meeting ,Joint Communiqu ,Cape Town Based ,World Health Organization Regional Director ,Deputy Chairperson ,Marketing Authorization Holder ,Emergency Use Authorizations ,New Technologies ,Private Securities Litigation Reform Act ,Emergency Use Authorization ,Annual Report ,Year Ended December ,Investegate Announcements ,Investegate Company Announcements ,Biontech Se ,Lobenewswire ,Lobenewswire And Globenewswire ,Nw ,